Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sponer, G
   Prolongation of repolarization in pre-clinical investigations and phase I/II clinical trials: what should be done?
   EUROPEAN HEART JOURNAL SUPPLEMENTS
   
   G. Sponer, "Prolongation of repolarization in pre-clinical investigations and phase I/II clinical trials: what should be done?", EUR H J SUP, 3(K), 2001, pp. K101-K104
2. Tillmann, HC; Sharpe, N; Sponer, G; Wehling, M
   Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trial
   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
   
   H.C. Tillmann et al., "Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trial", INT J CL PH, 39(5), 2001, pp. 205-212
3. Gonschior, P; Backfisch, G; Muth, G; Schiele, R; Vogel-Wiens, C; Pahl, C; Sponer, G
   Local drug delivery via transvascular injection
   JOURNAL OF INVASIVE CARDIOLOGY
   
   P. Gonschior et al., "Local drug delivery via transvascular injection", J INVAS CAR, 11(10), 1999, pp. 600-607
4. Beller, KD; Diedrich, F; Sponer, G
   Effects of carvedilol on contrast echocardiography in comparison to metoprolol in conscious dogs
   ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
   
   K.D. Beller et al., "Effects of carvedilol on contrast echocardiography in comparison to metoprolol in conscious dogs", ARZNEI-FOR, 49(10), 1999, pp. 830-834
5. MOHACSI P; PLUSS K; TSCHANZ HU; GASCHEN S; ASMIS R; SPONER G
   DOES CARVEDILOL INHIBIT AORTIC SMOOTH-MUSCLE CELL-PROLIFERATION
   Journal of the American College of Cardiology
   
   P. Mohacsi et al., "DOES CARVEDILOL INHIBIT AORTIC SMOOTH-MUSCLE CELL-PROLIFERATION", Journal of the American College of Cardiology, 31(2), 1998, pp. 469-470
6. PESCALLI N; SALA V; SPONER G; CESERANI R
   EFFECTS OF NAFTOPIDIL ON SOME URODYNAMIC PARAMETERS AND ARTERIAL BLOOD-PRESSURE IN COMPARISON WITH PRAZOSIN IN CONSCIOUS RATS
   Pharmacological research
   
   N. Pescalli et al., "EFFECTS OF NAFTOPIDIL ON SOME URODYNAMIC PARAMETERS AND ARTERIAL BLOOD-PRESSURE IN COMPARISON WITH PRAZOSIN IN CONSCIOUS RATS", Pharmacological research, 34(3-4), 1996, pp. 121-124
7. BAUSS F; KLING L; SPONER G
   COMPARISON OF CONTINUOUS AND CYCLICAL ADMINISTRATION OF IBANDRONATE ON BONE MASS IN OVARIECTOMIZED RATS
   Journal of bone and mineral research
   
   F. Bauss et al., "COMPARISON OF CONTINUOUS AND CYCLICAL ADMINISTRATION OF IBANDRONATE ON BONE MASS IN OVARIECTOMIZED RATS", Journal of bone and mineral research, 11, 1996, pp. 618-618
8. BAUSS F; SCHENK R; MULLERBECKMANN B; LALLA S; SPONER G
   BONE QUALITY FOLLOWING LONG-TERM TREATMENT OF IBANDRONATE IN ADULT BEAGLE DOGS
   Journal of bone and mineral research
   
   F. Bauss et al., "BONE QUALITY FOLLOWING LONG-TERM TREATMENT OF IBANDRONATE IN ADULT BEAGLE DOGS", Journal of bone and mineral research, 11, 1996, pp. 619-619
9. BAUSS F; ESSWEIN A; REIFF K; SPONER G; MULLERBECKMANN B
   EFFECT OF 17-BETA-ESTRADIOL-BISPHOSPHONATE CONJUGATES, POTENTIAL BONE-SEEKING ESTROGEN PRO-DRUGS, ON 17-BETA-ESTRADIOL SERUM KINETICS AND BONE MASS IN RATS
   Calcified tissue international
   
   F. Bauss et al., "EFFECT OF 17-BETA-ESTRADIOL-BISPHOSPHONATE CONJUGATES, POTENTIAL BONE-SEEKING ESTROGEN PRO-DRUGS, ON 17-BETA-ESTRADIOL SERUM KINETICS AND BONE MASS IN RATS", Calcified tissue international, 59(3), 1996, pp. 168-173
10. BAUSS F; ESSWEIN A; REIFF K; SPONER G; MULLERBECKMANN B
    17-BETA-ESTRADIOL-BISPHOSPHONATE CONJUGATES (E(2)-BPS) - POTENTIAL BONE SEEKING ESTROGEN-PRODRUGS - SERUM KINETIC AND IN-VIVO EFFECTS ON BONE MASS IN OVARIECTOMIZED RATS
    Journal of bone and mineral research
    
    F. Bauss et al., "17-BETA-ESTRADIOL-BISPHOSPHONATE CONJUGATES (E(2)-BPS) - POTENTIAL BONE SEEKING ESTROGEN-PRODRUGS - SERUM KINETIC AND IN-VIVO EFFECTS ON BONE MASS IN OVARIECTOMIZED RATS", Journal of bone and mineral research, 10, 1995, pp. 251-251
11. MARTIN U; FISCHER S; SPONER G
    INFLUENCE OF HEPARIN AND SYSTEMIC LYSIS ON CORONARY BLOOD-FLOW AFTER REPERFUSION-INDUCED BY THE NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR BM-06.022 IN A CANINE MODEL OF CORONARY-THROMBOSIS
    Journal of the American College of Cardiology
    
    U. Martin et al., "INFLUENCE OF HEPARIN AND SYSTEMIC LYSIS ON CORONARY BLOOD-FLOW AFTER REPERFUSION-INDUCED BY THE NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR BM-06.022 IN A CANINE MODEL OF CORONARY-THROMBOSIS", Journal of the American College of Cardiology, 22(3), 1993, pp. 914-920
12. MARTIN U; SPONER G; STREIN K
    EFFECTS OF THE NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR BM-06.022 ON HUMAN PLATELET-AGGREGATION INVITRO
    Fibrinolysis
    
    U. Martin et al., "EFFECTS OF THE NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR BM-06.022 ON HUMAN PLATELET-AGGREGATION INVITRO", Fibrinolysis, 7(3), 1993, pp. 203-210